FGFR1 Gene Kallmann Syndrome Type 2 Genetic Test
Test Name: FGFR1 Gene Kallmann Syndrome Type 2 Genetic Test
Components: Blood or Extracted DNA or One drop Blood on FTA Card
Price: 4400.0 AED
Report Delivery: 3 to 4 Weeks
Method: NGS Technology
Test Type: Hepatology Nephrology Endocrinology Disorders
Doctor: General Physician
Test Department: Genetics
Pre Test Information: Clinical History of Patient who is going for FGFR1 Gene Kallmann Syndrome Type 2 NGS Genetic DNA Test. A Genetic Counselling session to draw a pedigree chart of family members affected with FGFR1 Gene Kallmann Syndrome Type 2 NGS Genetic DNA Test gene FGFR1.
Test Details:
The FGFR1 gene is associated with Kallmann syndrome type 2, a rare genetic disorder characterized by delayed or absent puberty and an impaired sense of smell (anosmia or hyposmia). Kallmann syndrome type 2 is caused by mutations in the FGFR1 gene, which is responsible for encoding a protein involved in the development and functioning of the hypothalamus and olfactory system.
NGS (Next-Generation Sequencing) genetic testing is a method used to analyze multiple genes simultaneously and detect genetic variations, including mutations, in an individual’s DNA. In the context of Kallmann syndrome type 2, NGS genetic testing can be used to identify specific mutations in the FGFR1 gene that may be responsible for the disorder.
By analyzing the DNA sequence of the FGFR1 gene, NGS genetic testing can provide a definitive diagnosis of Kallmann syndrome type 2. This information can be crucial for appropriate medical management, genetic counseling, and family planning.
It is important to note that NGS genetic testing for Kallmann syndrome type 2 may require a healthcare provider’s prescription and should be performed by a qualified laboratory specializing in genetic testing. Genetic counseling is also recommended before and after testing to discuss the potential implications of the results and any further actions that may be necessary.
| Test Name | FGFR1 Gene Kallmann syndrome type 2 Genetic Test |
|---|---|
| Components | |
| Price | 4400.0 AED |
| Sample Condition | Blood or Extracted DNA or One drop Blood on FTA Card |
| Report Delivery | 3 to 4 Weeks |
| Method | NGS Technology |
| Test type | Hepatology Nephrology Endocrinology Disorders |
| Doctor | General Physician |
| Test Department: | Genetics |
| Pre Test Information | Clinical History of Patient who is going for FGFR1 Gene Kallmann syndrome type 2 NGS Genetic DNA Test. A Genetic Counselling session to draw a pedigree chart of family members affected with FGFR1 Gene Kallmann syndrome type 2 NGS Genetic DNA Test gene FGFR1 |
| Test Details | The FGFR1 gene is associated with Kallmann syndrome type 2, a rare genetic disorder characterized by delayed or absent puberty and an impaired sense of smell (anosmia or hyposmia). Kallmann syndrome type 2 is caused by mutations in the FGFR1 gene, which is responsible for encoding a protein involved in the development and functioning of the hypothalamus and olfactory system. NGS (Next-Generation Sequencing) genetic testing is a method used to analyze multiple genes simultaneously and detect genetic variations, including mutations, in an individual’s DNA. In the context of Kallmann syndrome type 2, NGS genetic testing can be used to identify specific mutations in the FGFR1 gene that may be responsible for the disorder. By analyzing the DNA sequence of the FGFR1 gene, NGS genetic testing can provide a definitive diagnosis of Kallmann syndrome type 2. This information can be crucial for appropriate medical management, genetic counseling, and family planning. It is important to note that NGS genetic testing for Kallmann syndrome type 2 may require a healthcare provider’s prescription and should be performed by a qualified laboratory specializing in genetic testing. Genetic counseling is also recommended before and after testing to discuss the potential implications of the results and any further actions that may be necessary. |
